speb/financial-data huggingface dataset:
Financial ratios for CKF.AX — annual report dated 2022-04-30
Total revenue: 840085815.602837
Gross profit: 441250354.6099291
Operating income: 8439716.312056739
Net income: 38864539.0070922
Capital expenditures: 45104964.5390071
Depreciation & amortization: 66024822.695035465
Net tangible assets: -57989361.702127665
Owner earnings: 59784397.16312057
Return on net tangible assets (%): -103.0954564911637
Capex to operating income (%): 534.436974789916
Buffett classification: The Gruesome
Stock price: 6.524822695035461
P/E ratio: 19.849371784156645
Shares outstanding: 118231057
Book value: 279097163.12056744
P/B ratio: 2.764043444033064
Market cap (USD): 771436683.9716312
Debt to equity: 1.9017322826642133
Current ratio: 0.6838529872844452
Quick ratio: 0.6362222128789289
Effective tax rate (%): 32.08615796453048
Interest coverage ratio: 0.3939484225510644
COGS to revenue (%): 47.47556185158388
SG&A to revenue (%): 34.42657411730142
Free cash flow (dilution-adjusted): 58948936.17021277
Buyback yield (%): 0
Retained earnings: 61887943.26241135
Inventory turnover: 70.91525851197983
Receivables turnover: 282.0288095238095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0658479043997129
FCF margin (%): 7.017013628293631
Rule of 40 score: 7.017013628293631
Financial ratios for CKF.AX — annual report dated 2023-04-30
Total revenue: 893121854.3046358
Gross profit: 447860264.90066224
Operating income: -37021192.05298013
Net income: 8441059.602649007
Capital expenditures: 43553642.38410596
Depreciation & amortization: 65002649.006622516
Net tangible assets: -71386754.96688741
Owner earnings: 29890066.22516557
Return on net tangible assets (%): -41.870605042952306
Buffett classification: The Gruesome
Stock price: 5.245033112582782
P/E ratio: 73.46539866938647
Shares outstanding: 118231057
Book value: 243415894.03973508
P/B ratio: 2.5475978524205702
Market cap (USD): 620125808.9006623
Debt to equity: 2.294516783745695
Current ratio: 0.6644891839794389
Quick ratio: 0.6220614182704566
Effective tax rate (%): 23.111535314971363
Interest coverage ratio: -1.6722606120434353
COGS to revenue (%): 49.85451730443255
SG&A to revenue (%): 37.23459789087166
Free cash flow (dilution-adjusted): 46748344.37086093
Buyback yield (%): 0
Retained earnings: 45288079.470198676
Inventory turnover: 80.81069711538461
Receivables turnover: 67.09856211751828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.760558438660823
FCF margin (%): 5.234262731960368
Revenue growth (%): 6.313169168764107
Rule of 40 score: 11.547431900724476
Financial ratios for CKF.AX — annual report dated 2024-04-30
Total revenue: 979528947.3684211
Gross profit: 494044736.84210527
Operating income: 5750000
Net income: 50474342.10526316
Capital expenditures: 50849342.10526316
Depreciation & amortization: 69526315.78947368
Net tangible assets: -50255921.05263158
Owner earnings: 69151315.78947368
Return on net tangible assets (%): -137.59834531149772
Capex to operating income (%): 884.3363844393593
Buffett classification: The Gruesome
Stock price: 6.223684210526316
P/E ratio: 14.578352722461908
Shares outstanding: 118231057
Book value: 268759210.5263158
P/B ratio: 2.7378885404661775
Market cap (USD): 735832762.6447369
Debt to equity: 2.0428724596953836
Current ratio: 0.5035331305650251
Quick ratio: 0.4600512740404495
Effective tax rate (%): 31.526220570317403
Interest coverage ratio: 0.21359792756244197
COGS to revenue (%): 49.563028415914204
SG&A to revenue (%): 33.75414068523807
Free cash flow (dilution-adjusted): 61606578.94736842
Buyback yield (%): 0
Retained earnings: 74219736.84210527
Inventory turnover: 77.97295012679628
Receivables turnover: 181.46057282145034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7279863265176932
FCF margin (%): 6.2894087114912915
Revenue growth (%): 9.67472609110656
Rule of 40 score: 15.964134802597851
Financial ratios for CKF.AX — annual report dated 2025-04-30
Total revenue: 967827388.5350318
Gross profit: 494537579.6178344
Operating income: -30686624.203821655
Net income: 5626751.592356687
Capital expenditures: 41882165.60509554
Depreciation & amortization: 70964331.21019109
Net tangible assets: -69591719.74522293
Owner earnings: 34708917.197452225
Return on net tangible assets (%): -49.87506750016016
Buffett classification: The Gruesome
Stock price: 5.101910828025478
P/E ratio: 107.20293938985738
Shares outstanding: 118231057
Book value: 258168152.86624205
P/B ratio: 2.3364783890665244
Market cap (USD): 603204309.9171975
Debt to equity: 2.197817054997977
Current ratio: 0.6215270990387639
Quick ratio: 0.577876271661808
Effective tax rate (%): 71.77275051124744
Interest coverage ratio: -1.1067515104178631
COGS to revenue (%): 48.90229544274424
SG&A to revenue (%): 36.99980717201639
Free cash flow (dilution-adjusted): 72314012.7388535
Buyback yield (%): 0
Retained earnings: 57614649.68152866
Inventory turnover: 72.3388823987539
Receivables turnover: 164.6785520754308
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8612675068624895
FCF margin (%): 7.471788213011085
Revenue growth (%): -1.1946108243994635
Rule of 40 score: 6.277177388611622
Financial ratios for CKF.AX — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: -69591719.74522293
Buffett classification: The Gruesome
Stock price: 5.101910828025478
Shares outstanding: 118231057
Book value: 258168152.86624205
P/B ratio: 2.3364783890665244
Market cap (USD): 603204309.9171975
Debt to equity: 2.197817054997977
Current ratio: 0.6215270990387639
Quick ratio: 0.577876271661808
Buyback yield (%): 0
Retained earnings: 57614649.68152866
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLC.L — annual report dated 2022-02-28
Total revenue: 2937333.3333333335
Net income: 2593333.3333333335
Capital expenditures: 0
Operating cash flow: -738666.6666666666
Net tangible assets: 40264000
Owner earnings: 2593333.3333333335
Return on net tangible assets (%): 6.440823895622227
Buffett classification: The Gruesome
Stock price: 0.005866666666666667
P/E ratio: 0.2217665671979434
Shares outstanding: 98030903
Book value: 40264000
P/B ratio: 0.014283594052586264
Market cap (USD): 575114.6309333333
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 11.711302768951429
Free cash flow (dilution-adjusted): -738666.6666666666
Buyback yield (%): 34.08016236379146
Receivables turnover: 9.834821428571429
Capitalized R&D asset: 0
FCF margin (%): -25.14752610077167
Rule of 40 score: -25.14752610077167
Financial ratios for CLC.L — annual report dated 2023-02-28
Total revenue: 1167469.8795180724
Net income: 780722.8915662651
Capital expenditures: 0
Net tangible assets: 41349397.590361446
Owner earnings: 780722.8915662651
Return on net tangible assets (%): 1.8881118881118881
Buffett classification: The Gruesome
Stock price: 0.006385542168674699
P/E ratio: 0.8017959658950616
Shares outstanding: 98030903
Book value: 41349397.59036145
P/B ratio: 0.0151388049504662
Market cap (USD): 625980.4649397591
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 33.126934984520126
Free cash flow (dilution-adjusted): -771084.3373493976
Buyback yield (%): 105.28062479421547
Receivables turnover: 7.021739130434783
Capitalized R&D asset: 0
FCF margin (%): -66.04747162022704
Revenue growth (%): -60.254089439920364
Rule of 40 score: -126.3015610601474
Financial ratios for CLC.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 55052000
Buffett classification: The Gruesome
Stock price: 0.007200000000000001
Shares outstanding: 98030903
Book value: 55052000
P/B ratio: 0.012821014706096055
Market cap (USD): 705822.5016000001
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLC.L — annual report dated 2025-03-31
Total revenue: 2085714.2857142857
Net income: 1677922.0779220778
Capital expenditures: 0
Net tangible assets: 59367532.46753246
Owner earnings: 1677922.0779220778
Return on net tangible assets (%): 2.8263294905169207
Buffett classification: The Gruesome
Stock price: 0.006753246753246752
P/E ratio: 0.39455162198142407
Shares outstanding: 98030903
Book value: 59367532.46753247
P/B ratio: 0.011151328847373831
Market cap (USD): 662026.8774025973
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 19.551681195516814
Free cash flow (dilution-adjusted): -712987.012987013
Buyback yield (%): 241.68203053589838
Receivables turnover: 1.0656934306569343
Capitalized R&D asset: 0
FCF margin (%): -34.184308841843084
Revenue growth (%): 78.65251363703375
Rule of 40 score: 44.468204795190665
Financial ratios for CLC.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 59367532.46753246
Buffett classification: The Gruesome
Stock price: 0.006753246753246752
Shares outstanding: 98030903
Book value: 59367532.46753247
P/B ratio: 0.011151328847373831
Market cap (USD): 662026.8774025973
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 281100000
Buffett classification: The Gruesome
Stock price: 21.66
Shares outstanding: 93348503
Market cap (USD): 2021928574.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNO — annual report dated 2022-12-31
Total revenue: 3576800000
Net income: 630600000
Capital expenditures: 0
Operating cash flow: 495400000
Depreciation & amortization: 309600000
Net tangible assets: 1768800000
Owner earnings: 940200000
Return on net tangible assets (%): 53.154681139755766
Buffett classification: The Gruesome
Stock price: 21.32
P/E ratio: 3.15602614012052
Shares outstanding: 93348503
Book value: 1768800000
P/B ratio: 1.12516400042967
Market cap (USD): 1990190083.96
Debt to equity: 2.195217096336499
Effective tax rate (%): 22.76791181873852
COGS to revenue (%): 0
SG&A to revenue (%): 8.049094162379781
Free cash flow (dilution-adjusted): 495400000
Buyback yield (%): 9.551851430278795
Retained earnings: 1691200000
Receivables turnover: 0.6765529242642052
Capitalized R&D asset: 0
FCF margin (%): 13.850369044956384
Rule of 40 score: 13.850369044956384
Financial ratios for CNO — annual report dated 2023-12-31
Total revenue: 4146800000
Net income: 276500000
Capital expenditures: 0
Operating cash flow: 582900000
Depreciation & amortization: 267400000
Net tangible assets: 2215600000
Owner earnings: 543900000
Return on net tangible assets (%): 24.54865499187579
Buffett classification: The Gruesome
Stock price: 26.66
P/E ratio: 9.000618770271247
Shares outstanding: 93348503
Book value: 2215600000
P/B ratio: 1.1232492733255102
Market cap (USD): 2488671089.98
Debt to equity: 1.8733525907203465
Effective tax rate (%): 22.505605381165918
COGS to revenue (%): 0
SG&A to revenue (%): 7.015047747660846
Free cash flow (dilution-adjusted): 582900000
Buyback yield (%): 6.674244767368388
Retained earnings: 1899800000
Receivables turnover: 0.8332094275553055
Capitalized R&D asset: 0
FCF margin (%): 14.056621973569982
Revenue growth (%): 15.93603220755983
Rule of 40 score: 29.99265418112981
Financial ratios for CNO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.09
Shares outstanding: 93348503
Market cap (USD): 3182250467.2700005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNO — annual report dated 2024-12-31
Total revenue: 4445600000
Net income: 420800000
Capital expenditures: 0
Operating cash flow: 627700000
Depreciation & amortization: 292400000
Net tangible assets: 2515200000
Owner earnings: 713200000
Return on net tangible assets (%): 28.35559796437659
Buffett classification: The Gruesome
Stock price: 36.29
P/E ratio: 8.05042104056559
Shares outstanding: 93348503
Book value: 2515200000
P/B ratio: 1.3468579730717238
Market cap (USD): 3387617173.87
Debt to equity: 1.7970340330788803
Effective tax rate (%): 22.059640674198928
COGS to revenue (%): 0
SG&A to revenue (%): 6.849469138024114
Free cash flow (dilution-adjusted): 627700000
Buyback yield (%): 8.861686093563305
Retained earnings: 2253100000
Receivables turnover: 0.9521932830705963
Capitalized R&D asset: 0
FCF margin (%): 14.119578909483534
Revenue growth (%): 7.205556091444006
Rule of 40 score: 21.32513500092754
Financial ratios for CNO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.29
Shares outstanding: 93348503
Market cap (USD): 3387617173.87
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNO — quarterly report dated 2025-03-31
Total revenue: 1004100000
Net income: 21500000
Capital expenditures: 0
Operating cash flow: 136700000
Depreciation & amortization: 77800000
Net tangible assets: 2530500000
Owner earnings: 99300000
Return on net tangible assets (%): 3.924125666864256
Buffett classification: The Gruesome
Stock price: 40.79
P/E ratio: 44.27541206244186
Shares outstanding: 93348503
Book value: 2530500000
P/B ratio: 1.5047166320371468
Market cap (USD): 3807685437.37
Debt to equity: 1.7379569255087928
Effective tax rate (%): 22.66187050359712
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 136700000
Buyback yield (%): 2.896772903493444
Retained earnings: 2233600000
Receivables turnover: 0.21926453247150282
Capitalized R&D asset: 0
FCF margin (%): 13.614181854396973
Rule of 40 score: 13.614181854396973
Financial ratios for CNO — quarterly report dated 2025-06-30
Total revenue: 1151500000
Net income: 91800000
Capital expenditures: 0
Operating cash flow: 145500000
Depreciation & amortization: 78800000
Net tangible assets: 2522700000
Owner earnings: 170600000
Return on net tangible assets (%): 6.762595631664486
Buffett classification: The Gruesome
Stock price: 37.95
P/E ratio: 31.267217024271847
Shares outstanding: 93348503
Book value: 2522700000
P/B ratio: 1.4042794184207399
Market cap (USD): 3542575688.8500004
Debt to equity: 1.636817695326436
Effective tax rate (%): 22.203389830508474
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 145500000
Buyback yield (%): 2.8312733109891473
Retained earnings: 2333000000
Receivables turnover: 0.25570705276248
Capitalized R&D asset: 0
FCF margin (%): 12.635692574902302
Revenue growth (%): 14.679812767652626
Rule of 40 score: 27.31550534255493
Financial ratios for CNO — quarterly report dated 2025-09-30
Total revenue: 1188700000
Net income: 23100000
Capital expenditures: 0
Operating cash flow: 197800000
Depreciation & amortization: 80100000
Net tangible assets: 2611000000
Owner earnings: 103200000
Return on net tangible assets (%): 3.952508617387974
Buffett classification: The Gruesome
Stock price: 39.07
P/E ratio: 26.738460500073312
Shares outstanding: 93348503
Book value: 2611000000
P/B ratio: 1.3968311038720795
Market cap (USD): 3647126012.21
Debt to equity: 1.5515894293374186
Effective tax rate (%): 36.187845303867405
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 197800000
Buyback yield (%): 1.6615822923891526
Retained earnings: 2339500000
Receivables turnover: 0.26773728546330916
Capitalized R&D asset: 0
FCF margin (%): 16.640026920164885
Revenue growth (%): 3.23056882327399
Rule of 40 score: 19.870595743438876
Financial ratios for CNO — annual report dated 2025-12-31
Total revenue: 4487400000
Net income: 229300000
Capital expenditures: 0
Operating cash flow: 675700000
Depreciation & amortization: 318500000
Net tangible assets: 2638200000
Owner earnings: 547800000
Return on net tangible assets (%): 20.76415738003184
Buffett classification: The Gruesome
Stock price: 42.14
P/E ratio: 17.15528092638465
Shares outstanding: 93348503
Book value: 2638200000
P/B ratio: 1.4910567494579638
Market cap (USD): 3933705916.42
Debt to equity: 1.5357819725570465
Effective tax rate (%): 21.84730743012952
COGS to revenue (%): 0
SG&A to revenue (%): 6.796808842536881
Free cash flow (dilution-adjusted): 675700000
Buyback yield (%): 8.424625710241237
Retained earnings: 2416000000
Receivables turnover: 1.022000546597431
Capitalized R&D asset: 0
FCF margin (%): 15.057717163613674
Revenue growth (%): 0.9402555335612741
Rule of 40 score: 15.997972697174948
Financial ratios for CNO — quarterly report dated 2025-12-31
Total revenue: 1143100000
Net income: 92900000
Capital expenditures: 0
Operating cash flow: 195700000
Depreciation & amortization: 81800000
Net tangible assets: 2638200000
Owner earnings: 174700000
Return on net tangible assets (%): 6.621939200970359
Buffett classification: The Gruesome
Stock price: 42.14
P/E ratio: 17.15528092638465
Shares outstanding: 93348503
Book value: 2638200000
P/B ratio: 1.4910567494579638
Market cap (USD): 3933705916.42
Debt to equity: 1.5357819725570465
Effective tax rate (%): 16.60682226211849
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 195700000
Buyback yield (%): 1.5303635116370624
Retained earnings: 2416000000
Receivables turnover: 0.2603398014029334
Capitalized R&D asset: 0
FCF margin (%): 17.120111976205056
Revenue growth (%): -3.836123496256415
Rule of 40 score: 13.283988479948642
Financial ratios for CNR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 111.04724409448819
Shares outstanding: 604900000
Market cap (USD): 67172477952.755905
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNR.TO — annual report dated 2022-12-31
Total revenue: 12578676470.588234
Gross profit: 5438235294.117646
Operating income: 5029411764.705882
Net income: 3763235294.1176467
Capital expenditures: 2022058823.5294116
Operating cash flow: 4902205882.352941
Depreciation & amortization: 1271323529.4117646
Net tangible assets: 15571323529.411764
Owner earnings: 3012500000
Return on net tangible assets (%): 19.346460782924872
Capex to operating income (%): 40.2046783625731
Buffett classification: The Good
Stock price: 109.38235294117645
P/E ratio: 17.582048456428293
Shares outstanding: 604900000
Book value: 15723529411.764706
P/B ratio: 4.208049195660306
Market cap (USD): 66165385294.11764
Debt to equity: 0.7433127572016461
Current ratio: 0.8373243102550755
Quick ratio: 0.657209786569495
Effective tax rate (%): 24.323525062841934
Interest coverage ratio: 12.481751824817518
COGS to revenue (%): 56.766236043724795
SG&A to revenue (%): -2.911089027883323
Free cash flow (dilution-adjusted): 2880147058.8235292
Buyback yield (%): 5.349785037324698
Retained earnings: 14359558823.529411
Inventory turnover: 14.033236994219653
Receivables turnover: 12.072688779110797
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.60914139256728
FCF margin (%): 22.897059683170635
Rule of 40 score: 22.897059683170635
Financial ratios for CNR.TO — annual report dated 2023-12-31
Total revenue: 12748484848.484848
Gross profit: 5417424242.424242
Operating income: 4997727272.727272
Net income: 4261363636.363636
Capital expenditures: 2316666666.6666665
Operating cash flow: 5276515151.515151
Depreciation & amortization: 1376515151.5151515
Net tangible assets: 15087878787.878788
Owner earnings: 3321212121.2121215
Return on net tangible assets (%): 22.012452299658566
Capex to operating income (%): 46.35440351675004
Buffett classification: The Good
Stock price: 119.07575757575758
P/E ratio: 16.902787911111112
Shares outstanding: 604900000
Book value: 15240151515.151516
P/B ratio: 4.726260476214147
Market cap (USD): 72028925757.57576
Debt to equity: 0.9389073917582144
Current ratio: 0.6135054617676267
Quick ratio: 0.47467725918570014
Effective tax rate (%): 13.301479654747226
Interest coverage ratio: 9.137119113573405
COGS to revenue (%): 57.50534822914191
SG&A to revenue (%): -2.8464463988590443
Free cash flow (dilution-adjusted): 2862121212.121212
Buyback yield (%): 4.816036554001422
Retained earnings: 14132575757.575756
Inventory turnover: 13.84406294706724
Receivables turnover: 12.944615384615386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.850223593877933
FCF margin (%): 22.450677442357975
Revenue growth (%): 1.3499701522148546
Rule of 40 score: 23.80064759457283
Financial ratios for CNR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 112.39259259259258
Shares outstanding: 604900000
Market cap (USD): 67986279259.25925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNR.TO — annual report dated 2024-12-31
Total revenue: 11920279720.27972
Gross profit: 4872027972.027972
Operating income: 4423076923.076923
Net income: 3110489510.4895105
Capital expenditures: 2481818181.818182
Operating cash flow: 4684615384.615385
Depreciation & amortization: 1323076923.0769231
Net tangible assets: 14581818181.818182
Owner earnings: 1951748251.748252
Return on net tangible assets (%): 13.384807212737387
Capex to operating income (%): 56.11067193675889
Buffett classification: The Good
Stock price: 98.34965034965035
P/E ratio: 19.12615467625899
Shares outstanding: 604900000
Book value: 14720979020.979023
P/B ratio: 4.04128715975488
Market cap (USD): 59491703496.503494
Debt to equity: 1.015201178091302
Current ratio: 0.6587022132796782
Quick ratio: 0.47761569416498995
Effective tax rate (%): 23.991797676008204
Interest coverage ratio: 7.098765432098765
COGS to revenue (%): 59.128241229613984
Free cash flow (dilution-adjusted): 2202797202.797203
Buyback yield (%): 3.1149668680369325
Retained earnings: 12834965034.965036
Inventory turnover: 13.99861111111111
Receivables turnover: 13.042081101759754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.913506997419523
FCF margin (%): 18.479408658922917
Revenue growth (%): -6.496498509809655
Rule of 40 score: 11.982910149113263
Financial ratios for CNR.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 98.34965034965035
Shares outstanding: 604900000
Market cap (USD): 59491703496.503494
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNR.TO — quarterly report dated 2025-03-31
Total revenue: 3079020979.020979
Gross profit: 1242657342.6573427
Operating income: 1125874125.874126
Net income: 811888111.888112
Capital expenditures: 362937062.937063
Operating cash flow: 813986013.986014
Depreciation & amortization: 344755244.7552448
Net tangible assets: 14778321678.321678
Owner earnings: 793706293.7062938
Return on net tangible assets (%): 5.37074717266834
Capex to operating income (%): 32.2360248447205
Buffett classification: The Good
Stock price: 94.93006993006993
P/E ratio: 17.681992894056847
Shares outstanding: 604900000
Book value: 15121678321.678326
P/B ratio: 3.797409128745837
Market cap (USD): 57423199300.6993
Debt to equity: 0.9772937476877541
Current ratio: 0.6208816705336427
Quick ratio: 0.4331786542923434
Effective tax rate (%): 23.968565815324165
Interest coverage ratio: 6.909871244635193
COGS to revenue (%): 59.641153758800826
Free cash flow (dilution-adjusted): 451048951.0489511
Buyback yield (%): 0.1972838759705499
Retained earnings: 13202797202.797203
Inventory turnover: 3.245982694684796
Receivables turnover: 3.5027844073190133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.032414819279378
FCF margin (%): 14.649102884397003
Rule of 40 score: 14.649102884397003
Financial ratios for CNR.TO — quarterly report dated 2025-06-30
Total revenue: 3118248175.1824813
Gross profit: 1333576642.3357663
Operating income: 1195620437.9562042
Net income: 855474452.5547445
Capital expenditures: 587591240.8759123
Operating cash flow: 1273722627.7372262
Depreciation & amortization: 356934306.56934303
Net tangible assets: 15366423357.664232
Owner earnings: 624817518.2481753
Return on net tangible assets (%): 4.06612198365951
Capex to operating income (%): 49.14529914529914
Buffett classification: The Good
Stock price: 101.02189781021897
P/E ratio: 36.64958497243252
Shares outstanding: 604900000
Book value: 15719708029.197079
P/B ratio: 3.887358841010401
Market cap (USD): 61108145985.40146
Debt to equity: 0.9636887072808321
Current ratio: 0.817041892277002
Quick ratio: 0.5842120262182958
Effective tax rate (%): 24.91992312620115
Interest coverage ratio: 7.47945205479452
COGS to revenue (%): 57.23314606741573
Free cash flow (dilution-adjusted): 686131386.8613138
Buyback yield (%): 0.3619286424833034
Retained earnings: 14014598540.145985
Inventory turnover: 2.99265605875153
Receivables turnover: 3.777188328912467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.075074624063679
FCF margin (%): 22.00374531835206
Revenue growth (%): 1.2740152285021207
Rule of 40 score: 23.277760546854182
Financial ratios for CNR.TO — quarterly report dated 2025-09-30
Total revenue: 2996402877.697842
Gross profit: 1271223021.5827339
Operating income: 1155395683.4532375
Net income: 819424460.4316547
Capital expenditures: 794964028.7769785
Operating cash flow: 1376258992.8057554
Depreciation & amortization: 359712230.21582735
Net tangible assets: 14944604316.546764
Owner earnings: 384172661.8705034
Return on net tangible assets (%): 2.570644586723149
Capex to operating income (%): 68.80448318804483
Buffett classification: The Good
Stock price: 92.71223021582735
P/E ratio: 22.55184199394155
Shares outstanding: 604900000
Book value: 15304316546.762592
P/B ratio: 3.664432050016453
Market cap (USD): 56081628057.55396
Debt to equity: 1.0087434776477224
Current ratio: 0.6019650131799664
Quick ratio: 0.41504912532949917
Effective tax rate (%): 24.419376244193764
Interest coverage ratio: 7.07488986784141
COGS to revenue (%): 57.5750300120048
Free cash flow (dilution-adjusted): 581294964.028777
Buyback yield (%): 1.3328464958638206
Retained earnings: 13517266187.05036
Inventory turnover: 3.074358974358974
Receivables turnover: 3.3426966292134837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.002935621996597
FCF margin (%): 19.399759903961584
Revenue growth (%): -3.9074919839409104
Rule of 40 score: 15.492267920020673
Financial ratios for CNR.TO — annual report dated 2025-12-31
Total revenue: 12630656934.306568
Gross profit: 5351824817.518248
Operating income: 4808029197.080292
Net income: 3445255474.4525547
Capital expenditures: 2670072992.70073
Operating cash flow: 5145255474.452555
Depreciation & amortization: 1414598540.1459854
Net tangible assets: 15582481751.824816
Owner earnings: 2189781021.8978105
Return on net tangible assets (%): 14.052838673412033
Capex to operating income (%): 55.53362684074693
Buffett classification: The Good
Stock price: 97.93430656934305
P/E ratio: 17.194795127118642
Shares outstanding: 604900000
Book value: 15743065693.430653
P/B ratio: 3.7629559068991103
Market cap (USD): 59240462043.79561
Debt to equity: 1.002874629080119
Current ratio: 0.668560606060606
Quick ratio: 0.4699675324675324
Effective tax rate (%): 24.648786717752234
Interest coverage ratio: 7.214676889375684
COGS to revenue (%): 57.62829403606102
Free cash flow (dilution-adjusted): 2475182481.751825
Buyback yield (%): 2.605981734741789
Retained earnings: 13808759124.08759
Inventory turnover: 13.5858310626703
Receivables turnover: 15.491495076096689
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.007145591425292
FCF margin (%): 19.59662505779011
Revenue growth (%): 5.9594005400586205
Rule of 40 score: 25.55602559784873
Financial ratios for CNR.TO — quarterly report dated 2025-12-31
Total revenue: 3258394160.5839415
Gross profit: 1431386861.3138685
Operating income: 1264963503.6496348
Net income: 910948905.109489
Capital expenditures: 897080291.9708029
Operating cash flow: 1625547445.2554743
Depreciation & amortization: 332846715.32846713
Net tangible assets: 15582481751.824816
Owner earnings: 346715328.4671532
Return on net tangible assets (%): 2.2250327899569045
Capex to operating income (%): 70.91748413156377
Buffett classification: The Good
Stock price: 97.93430656934305
P/E ratio: 17.435275508321972
Shares outstanding: 604900000
Book value: 15743065693.430653
P/B ratio: 3.7629559068991103
Market cap (USD): 59240462043.79561
Debt to equity: 1.002874629080119
Current ratio: 0.668560606060606
Quick ratio: 0.4699675324675324
Effective tax rate (%): 25.22468544038346
Interest coverage ratio: 7.405982905982905
COGS to revenue (%): 56.070788530465954
Free cash flow (dilution-adjusted): 728467153.2846714
Buyback yield (%): 0.7528391678142948
Retained earnings: 13808759124.08759
Inventory turnover: 3.41008174386921
Receivables turnover: 3.996418979409132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.159007637762264
FCF margin (%): 22.356630824372758
Revenue growth (%): 8.743526607723362
Rule of 40 score: 31.10015743209612
Financial ratios for COGN3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.36666666666666664
Shares outstanding: 2001229192
Market cap (USD): 733784037.0666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGN3.SA — annual report dated 2022-12-31
Total revenue: 947877462.1212121
Gross profit: 603720075.7575758
Operating income: 96981818.18181817
Net income: -100176136.36363636
Capital expenditures: 28045265.15151515
Operating cash flow: 22224810.606060605
Depreciation & amortization: 176243371.21212122
Net tangible assets: -563564962.1212121
Owner earnings: 48021969.69696971
Capex to operating income (%): 28.918064929383824
Buffett classification: The Good
Stock price: 0.34155597722960157
Shares outstanding: 2001229192
Book value: 2507838636.3636365
P/B ratio: 0.27255812332690044
Market cap (USD): 683531792.3339659
Debt to equity: 0.6195969032853655
Current ratio: 1.2433967401588193
Quick ratio: 1.1386307349854201
Interest coverage ratio: 0.4416671194913872
COGS to revenue (%): 36.30821494515358
SG&A to revenue (%): 44.40577262636037
Free cash flow (dilution-adjusted): -67880871.2121212
Buyback yield (%): 0.6225187597835443
Inventory turnover: 4.262390868873762
Receivables turnover: 2.488574954701588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.293425682342108
FCF margin (%): -7.161355124977196
Rule of 40 score: -7.161355124977196
Financial ratios for COGN3.SA — annual report dated 2023-12-31
Total revenue: 1198927422.6804125
Gross profit: 764038350.515464
Operating income: 154807422.68041238
Net income: -101624536.08247423
Capital expenditures: 24997525.773195878
Operating cash flow: 140174639.17525774
Depreciation & amortization: 189081443.2989691
Net tangible assets: -680877938.1443299
Owner earnings: 62459381.44329898
Capex to operating income (%): 16.147498188637428
Buffett classification: The Great
Stock price: 0.6149068322981367
Shares outstanding: 2001229192
Book value: 2619851340.206186
P/B ratio: 0.4697096679762113
Market cap (USD): 1230569503.1552796
Debt to equity: 0.6119491001260086
Current ratio: 1.3745411606342097
Quick ratio: 1.2447764054873949
Interest coverage ratio: 0.7058631079689945
COGS to revenue (%): 36.273177503328576
SG&A to revenue (%): 42.471071222078564
Free cash flow (dilution-adjusted): 39527422.680412374
Buyback yield (%): 0.9368221293572655
Inventory turnover: 4.4254742376842975
Receivables turnover: 2.5660456458672214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4981861117423003
FCF margin (%): 3.296898705681607
Revenue growth (%): 26.485486847359685
Rule of 40 score: 29.78238555304129
Financial ratios for COGN3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.20073664825046042
Shares outstanding: 2001229192
Market cap (USD): 401720040.3830571
Buyback yield (%): 0
Retained earnings: -8463535.91160221
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGN3.SA — annual report dated 2024-12-31
Total revenue: 1034076537.2168286
Gross profit: 692150970.8737864
Operating income: 220755339.80582526
Net income: 160458090.61488673
Capital expenditures: 17039805.82524272
Operating cash flow: 140361812.29773465
Depreciation & amortization: 149898543.6893204
Net tangible assets: -380429449.8381877
Owner earnings: 293316828.4789644
Return on net tangible assets (%): -77.10150426149292
Capex to operating income (%): 7.718864621907133
Buffett classification: The Great
Stock price: 0.15024232633279483
P/E ratio: 1.8738184418061639
Shares outstanding: 2001229192
Book value: 2191769417.475728
P/B ratio: 0.13718109529854727
Market cap (USD): 300669329.3311793
Debt to equity: 0.5074303061578936
Current ratio: 1.6061348317648696
Quick ratio: 1.4570711374332403
Effective tax rate (%): -50.10198693480984
Interest coverage ratio: 1.415343500917614
COGS to revenue (%): 33.065789043364205
SG&A to revenue (%): 36.47664622046811
Free cash flow (dilution-adjusted): 69524919.09385113
Buyback yield (%): 2.8868170498436942
Inventory turnover: 4.92035365260175
Receivables turnover: 2.6400154502998143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.399202827216581
FCF margin (%): 6.7233823214840935
Revenue growth (%): -13.749863615182884
Rule of 40 score: -7.02648129369879
Financial ratios for COGN3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.15024232633279483
Shares outstanding: 2001229192
Market cap (USD): 300669329.3311793
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGN3.SA — quarterly report dated 2025-03-31
Total revenue: 282574305.5555556
Gross profit: 205607291.6666667
Operating income: 52727604.16666667
Net income: 16511979.166666668
Capital expenditures: 15351041.666666668
Operating cash flow: 52829687.5
Depreciation & amortization: 39757638.88888889
Net tangible assets: -392607118.0555556
Owner earnings: 40918576.38888888
Return on net tangible assets (%): -10.422270638276794
Capex to operating income (%): 29.113861532838786
Buffett classification: The Good
Stock price: 0.3090277777777778
P/E ratio: 9.363435536489712
Shares outstanding: 2001229192
Book value: 2359985937.5
P/B ratio: 0.26205046403068993
Market cap (USD): 618435410.0277778
Debt to equity: 0.5056668549181416
Current ratio: 1.3825954168905363
Quick ratio: 1.2501798048688018
Effective tax rate (%): 24.137320400853223
Interest coverage ratio: 1.399028960739243
COGS to revenue (%): 27.237796351500464
SG&A to revenue (%): 44.136252264030844
Free cash flow (dilution-adjusted): 36098090.27777778
Buyback yield (%): 1.6791365487195458
Retained earnings: 16511979.166666668
Inventory turnover: 0.982440044852788
Receivables turnover: 0.6781503596309986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.46042434249264
FCF margin (%): 12.774724937147802
Rule of 40 score: 12.774724937147802
Financial ratios for COGN3.SA — quarterly report dated 2025-06-30
Total revenue: 303759124.08759123
Gross profit: 208223540.1459854
Operating income: 86172810.21897809
Net income: 21678649.635036495
Capital expenditures: 17171715.328467153
Operating cash flow: 43041788.32116788
Depreciation & amortization: 41060948.90510949
Net tangible assets: -384602919.70802915
Owner earnings: 45567883.211678825
Return on net tangible assets (%): -11.848033615104022
Capex to operating income (%): 19.927068973184507
Buffett classification: The Great
Stock price: 0.4470802919708029
P/E ratio: 23.42747840328707
Shares outstanding: 2001229192
Book value: 2500306934.306569
P/B ratio: 0.3578401192203994
Market cap (USD): 894710131.459854
Debt to equity: 0.46590141268787294
Current ratio: 1.5326535548561535
Quick ratio: 1.3573077983321455
Effective tax rate (%): 2.018893587098326
Interest coverage ratio: 2.0621626578630194
COGS to revenue (%): 31.451099363210382
SG&A to revenue (%): 39.97140454163162
Free cash flow (dilution-adjusted): 25456569.343065694
Buyback yield (%): 0
Retained earnings: 39034306.56934306
Inventory turnover: 1.073085894424426
Receivables turnover: 0.6997148764864107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2630278760627465
FCF margin (%): 8.380511834674998
Revenue growth (%): 7.497078862278441
Rule of 40 score: 15.877590696953439
Financial ratios for COGN3.SA — quarterly report dated 2025-09-30
Total revenue: 286347556.39097744
Gross profit: 196935902.25563908
Operating income: 37648872.180451125
Net income: 36015977.44360902
Capital expenditures: 16770112.781954886
Operating cash flow: 85532142.85714285
Depreciation & amortization: 42981766.91729323
Net tangible assets: -361281766.9172932
Owner earnings: 62227631.578947365
Return on net tangible assets (%): -17.224127336930593
Capex to operating income (%): 44.543466538853274
Buffett classification: The Good
Stock price: 0.5488721804511277
P/E ratio: 14.802173091764029
Shares outstanding: 2001229192
Book value: 2610112593.9849625
P/B ratio: 0.42083204867361246
Market cap (USD): 1098419030.1954885
Debt to equity: 0.4594867749417948
Current ratio: 1.812487242796974
Quick ratio: 1.5842947776254481
Effective tax rate (%): -1358.305334753749
Interest coverage ratio: 0.9126042838982471
COGS to revenue (%): 31.22487066495379
SG&A to revenue (%): 45.20382126720446
Free cash flow (dilution-adjusted): 68762030.07518797
Buyback yield (%): 0
Retained earnings: 76224248.12030075
Inventory turnover: 0.8736770956164615
Receivables turnover: 0.7330649127416532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9343447984771485
FCF margin (%): 24.013485898689023
Revenue growth (%): -5.732031177306474
Rule of 40 score: 18.28145472138255
Financial ratios for COGN3.SA — annual report dated 2025-12-31
Total revenue: 1280412956.2043796
Gross profit: 880847445.2554743
Operating income: 241357481.7518248
Net income: 114145802.91970801
Capital expenditures: 26726642.33576642
Operating cash flow: 234601459.85401458
Depreciation & amortization: 167016605.83941606
Net tangible assets: -224648905.10948902
Owner earnings: 254435766.4233576
Return on net tangible assets (%): -113.25929512069115
Capex to operating income (%): 11.073467514567467
Buffett classification: The Great
Stock price: 0.5637342908438061
P/E ratio: 9.883512932679706
Shares outstanding: 2001229192
Book value: 2455246350.3649626
P/B ratio: 0.45949015226123696
Market cap (USD): 1128161519.3680432
Debt to equity: 0.4942361619502408
Current ratio: 1.6611819861578738
Quick ratio: 1.458046133355002
Effective tax rate (%): -1.217997765046642
Interest coverage ratio: 1.4673359308089302
COGS to revenue (%): 31.205987803604074
SG&A to revenue (%): 39.619317615795424
Free cash flow (dilution-adjusted): 136657481.7518248
Buyback yield (%): 0.9675000712454557
Inventory turnover: 3.8082052405847913
Receivables turnover: 2.8498275481126956
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.211760884597049
FCF margin (%): 10.672922441907213
Revenue growth (%): 23.821874892409276
Rule of 40 score: 34.49479733431649
Financial ratios for COGN3.SA — quarterly report dated 2025-12-31
Total revenue: 401654379.5620438
Gross profit: 265325182.4817518
Operating income: 93783029.19708028
Net income: 40147080.2919708
Capital expenditures: 44501094.89051095
Operating cash flow: 52995802.91970803
Depreciation & amortization: 42439781.02189781
Net tangible assets: -224648905.10948902
Owner earnings: 38085766.423357666
Return on net tangible assets (%): -16.95346184963398
Capex to operating income (%): 47.4511169787384
Buffett classification: The Good
Stock price: 0.5637342908438061
P/E ratio: 9.86554569012715
Shares outstanding: 2001229192
Book value: 2455246350.3649626
P/B ratio: 0.45949015226123696
Market cap (USD): 1128161519.3680432
Debt to equity: 0.4942361619502408
Current ratio: 1.6611819861578738
Quick ratio: 1.458046133355002
Effective tax rate (%): 37.8313490758403
Interest coverage ratio: 2.2137503553675577
COGS to revenue (%): 33.941917234649026
SG&A to revenue (%): 32.14783200503756
Free cash flow (dilution-adjusted): 8494708.02919708
Buyback yield (%): 0
Inventory turnover: 1.2993352742906636
Receivables turnover: 0.8939660522408185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.413671820641797
FCF margin (%): 2.11492976584982
Revenue growth (%): 40.268135906013114
Rule of 40 score: 42.38306567186294
Financial ratios for CRAMC.NS — quarterly report dated 2025-12-31
Total revenue: 12227926.924362259
Gross profit: 8574791.132895177
Operating income: 6605692.324830121
Net income: 5876540.046786232
Capital expenditures: 0
Depreciation & amortization: 219004.12164420186
Owner earnings: 6095544.168430434
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.473543500055698
P/E ratio: 29.515702854128484
Shares outstanding: 199417428
Market cap (USD): 692685110.8272252
Effective tax rate (%): 25.158043775572164
Interest coverage ratio: 117.19229249011858
COGS to revenue (%): 29.87534856941918
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.678977631182909
Rule of 40 score: 7.678977631182909
Financial ratios for CYIENTDLM.NS — annual report dated 2024-03-31
Total revenue: 142927329.41599712
Gross profit: 32607147.139944836
Operating income: 10636766.99844106
Net income: 7338529.799736179
Capital expenditures: 4049766.159011872
Operating cash flow: -8459167.765919175
Depreciation & amortization: 2675620.5780069553
Net tangible assets: 108370667.94579686
Owner earnings: 5964384.218731262
Return on net tangible assets (%): 5.50368871188875
Capex to operating income (%): 38.073280721533266
Buffett classification: The Good
Stock price: 8.642034548944338
P/E ratio: 93.46147946592203
Shares outstanding: 79364396
Book value: 109003237.79829717
P/B ratio: 6.292197058010825
Market cap (USD): 685869852.1880999
Debt to equity: 0.21135715055809928
Current ratio: 2.446045939309637
Quick ratio: 1.5896528632280746
Effective tax rate (%): 25.497023338487203
Interest coverage ratio: 2.689590345371297
COGS to revenue (%): 77.18620555412457
R&D to revenue (%): 0.024079787158173997
SG&A to revenue (%): 1.1870412150308214
Free cash flow (dilution-adjusted): -13162369.5886797
Buyback yield (%): 0
Retained earnings: 19019186.952872045
Inventory turnover: 1.9817370680648572
Receivables turnover: 5.276824176845871
Capitalized R&D asset: 59762.31875451193
ROCI (R&D-adjusted, %): 8.357507543012552
Rosenberg metric: 515.1954013945674
FCF margin (%): -9.209134209994204
Revenue growth (%): 41.03207138482924
Rule of 40 score: 31.822937174835033
Financial ratios for CYIENTDLM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 111424151.9350215
Buffett classification: The Gruesome
Stock price: 7.990922121356904
Shares outstanding: 79364396
Book value: 111967749.64166267
P/B ratio: 5.664083717625674
Market cap (USD): 634194707.6445295
Debt to equity: 0.36635715611578484
Current ratio: 2.2182550726104338
Quick ratio: 1.3907775894348025
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYIENTDLM.NS — quarterly report dated 2024-12-31
Total revenue: 51781792.749737725
Gross profit: 13820258.771418579
Operating income: 2111201.771768271
Net income: 1281151.6493763842
Capital expenditures: 0
Depreciation & amortization: 1168201.422077165
Owner earnings: 2449353.071453549
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.805105490150367
P/E ratio: 120.87708025111453
Shares outstanding: 79364396
Market cap (USD): 619447482.9420679
Effective tax rate (%): 26.770604304084216
Interest coverage ratio: 1.8197528383401989
COGS to revenue (%): 73.31058266326907
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYIENTDLM.NS — annual report dated 2025-03-31
Total revenue: 177650923.54454055
Gross profit: 48098199.67266776
Operating income: 12273439.326630816
Net income: 7958382.043488426
Capital expenditures: 19393266.308159925
Operating cash flow: -7294131.400514379
Depreciation & amortization: 3981996.7266775775
Net tangible assets: 96788987.60813653
Owner earnings: -7452887.537993921
Return on net tangible assets (%): -7.700139987172876
Capex to operating income (%): 158.01003933820377
Buffett classification: The Gruesome
Stock price: 5.340763216244603
P/E ratio: 53.26037937360386
Shares outstanding: 79364396
Book value: 110993102.6420388
P/B ratio: 3.818853935485269
Market cap (USD): 423866446.8362703
Debt to equity: 0.31728659676544474
Current ratio: 2.4012271547807513
Quick ratio: 1.3309364783468072
Effective tax rate (%): 25.78169290480136
Interest coverage ratio: 2.8684972677595635
COGS to revenue (%): 72.92544349728156
R&D to revenue (%): 0.03448216863886246
SG&A to revenue (%): 1.8530217303468088
Free cash flow (dilution-adjusted): -27385901.33270984
Buyback yield (%): 0
Retained earnings: 26459317.278466213
Inventory turnover: 1.939867628961985
Receivables turnover: 4.3743210217704815
Capitalized R&D asset: 90627.60767679241
ROCI (R&D-adjusted, %): 9.06026905340215
Rosenberg metric: 450.10413613371577
FCF margin (%): -15.4155693571971
Revenue growth (%): 24.294579819286124
Rule of 40 score: 8.879010462089024
Financial ratios for CYIENTDLM.NS — quarterly report dated 2025-03-31
Total revenue: 50041501.05213935
Gross profit: 17237666.588730417
Operating income: 5487257.423427636
Net income: 3628127.1919569788
Capital expenditures: 0
Depreciation & amortization: 1224807.1077858312
Net tangible assets: 96788987.60813653
Owner earnings: 4852934.29974281
Return on net tangible assets (%): 5.013932286791323
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.340763216244603
P/E ratio: 29.206972661812923
Shares outstanding: 79364396
Book value: 110993102.6420388
P/B ratio: 3.818853935485269
Market cap (USD): 423866446.8362703
Debt to equity: 0.31728659676544474
Current ratio: 2.4012271547807513
Quick ratio: 1.3309364783468072
Effective tax rate (%): 25.513020520820834
Interest coverage ratio: 5.464260768335273
COGS to revenue (%): 65.55325834296994
Buyback yield (%): 0
Retained earnings: 26459317.278466213
Inventory turnover: 0.49119072667533736
Receivables turnover: 1.232178170795948
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.0458282406361885
Revenue growth (%): -3.3608177801205814
Rule of 40 score: -3.3608177801205814
Financial ratios for CYIENTDLM.NS — quarterly report dated 2025-06-30
Total revenue: 32579803.416803185
Gross profit: 13099110.695062019
Operating income: 1701497.7767376553
Net income: 873274.0463374679
Capital expenditures: 0
Depreciation & amortization: 1230634.2148373509
Owner earnings: 2103908.2611748185
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.5546454481628835
P/E ratio: 76.23641141744301
Shares outstanding: 79364396
Market cap (USD): 440841080.9875966
Effective tax rate (%): 26.116226116226116
Interest coverage ratio: 1.687674094707521
COGS to revenue (%): 59.79377000075423
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -34.89443215770533
Rule of 40 score: -34.89443215770533
Financial ratios for CYIENTDLM.NS — quarterly report dated 2025-12-31
Total revenue: 33791578.47833352
Gross profit: 13916787.345438343
Operating income: 1862537.5960788683
Net income: 1251308.9005235604
Capital expenditures: 0
Depreciation & amortization: 1200066.8374735436
Owner earnings: 2451375.737997104
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.631279937618358
P/E ratio: 52.25560951068273
Shares outstanding: 79364396
Market cap (USD): 367558734.95599866
Effective tax rate (%): 24.646139397598443
Interest coverage ratio: 2.7387387387387387
COGS to revenue (%): 58.81581159530176
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.719405688327003
Rule of 40 score: 3.719405688327003
Financial ratios for DCOM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.77
Shares outstanding: 44113491
Market cap (USD): 1313258627.07
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCOM — annual report dated 2022-12-31
Total revenue: 418019000
Net income: 152556000
Capital expenditures: 1831000
Operating cash flow: 295172000
Depreciation & amortization: 10192000
Net tangible assets: 1007302000
Owner earnings: 160917000
Return on net tangible assets (%): 15.975050183559647
Buffett classification: The Gruesome
Stock price: 27.74
P/E ratio: 8.021370777550539
Shares outstanding: 44113491
Book value: 1169583000
P/B ratio: 1.0462773829133973
Market cap (USD): 1223708240.34
Debt to equity: 1.1898454406399546
Effective tax rate (%): 28.010759030743458
COGS to revenue (%): 0
SG&A to revenue (%): 31.077056306053073
Free cash flow (dilution-adjusted): 287149000
Buyback yield (%): 3.8213357120981275
Retained earnings: 762762000
Receivables turnover: 8.608121743786166
Capitalized R&D asset: 0
FCF margin (%): 68.69281061387161
Rule of 40 score: 68.69281061387161